Literature DB >> 25312200

A variant of DC-SIGN gene promoter associated with resistance to HIV-1 in serodiscordant couples in Burkina Faso.

Thérèse Samdapawindé Kagoné1, Cyrille Bisseye2, Nicolas Méda3, Jean Testa3, Virginio Pietra4, Dramane Kania3, Albert Théophane Yonli5, Tegwindé Rebeca Compaoré5, Jean Baptiste Nikiéma5, Comlan de Souza6, Jacques Simpore5.   

Abstract

OBJECTIVE: To study the involvement of variations in 4 genes associated with susceptibility and/or protection against HIV-1 in serodiscordant couples in Burkina Faso, namely, genes encoding HLA-B57, interferon regulatory factor 1 (IRF1), dendritic cell-specific ICAM3-grabbing nonintegrin (DC-SIGN) and CCR5 delta 32 (CCR5Δ32).
METHODS: Two DC-SIGN and two IRF1 single nucleotide polymorphisms (SNPs) as well as HLA-B57*01 and CCR5Δ32 alleles were genotyped in 51 serodiscordant couples in Burkina Faso. DC-SIGN, IRF1 and HLA-B57*01 genotyping was carried out by real time PCR using TaqMan assays (Applied Biosystems, USA and Sacace Biotechnologies, Italy). CCR5Δ32 deletion was investigated by PCR.
RESULTS: The two SNPs of DC-SIGN promoter showed a significant genotypic difference in serodiscordant couples. After multivariate analysis, only the association between DC-SIGN rs2287886 and HIV-1 remained significant (P<0.01). No association was found between IRF1 SNPs and HIV-1 infection. CCR5Δ32 wild type allele was found in 100% of serodiscordant couples. A high frequency of HLA-B57*01 allele was found in the HIV-positive (78%) compared with HIV-negative group (51%), however this difference was no longer significant after the correction of the sex confounding effect in the logistic regression model.
CONCLUSIONS: Our study suggests a protective role of a variation of DC-SIGN promoter and genetic resistance to HIV-1 in serodiscordant couples in Burkina Faso.
Copyright © 2014 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Burkina Faso; Genetic resistance; HIV-1

Year:  2014        PMID: 25312200     DOI: 10.1016/S1995-7645(14)60211-X

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  6 in total

1.  DC-SIGN Polymorphisms Associate with Risk of Hepatitis C Virus Infection Among Men who Have Sex with Men but not Among Injecting Drug Users.

Authors:  Gaby S Steba; Sylvie M Koekkoek; Joost W Vanhommerig; Kees Brinkman; David Kwa; Jan T M Van Der Meer; Maria Prins; Ben Berkhout; Michael Tanck; William A Paxton; Richard Molenkamp; Janke Schinkel
Journal:  J Infect Dis       Date:  2018-01-17       Impact factor: 5.226

Review 2.  C-type Lectin CD209L/L-SIGN and CD209/DC-SIGN: Cell Adhesion Molecules Turned to Pathogen Recognition Receptors.

Authors:  Nader Rahimi
Journal:  Biology (Basel)       Date:  2020-12-22

3.  APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso.

Authors:  Tegwinde Rebeca Compaore; Serge Theophile Soubeiga; Abdoul Karim Ouattara; Dorcas Obiri-Yeboah; Damehan Tchelougou; Mamoudou Maiga; Maleki Assih; Cyrille Bisseye; Didier Bakouan; Issaka Pierre Compaore; Augustine Dembele; Jeremy Martinson; Jacques Simpore
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

Review 4.  Human lectins and their roles in viral infections.

Authors:  Christopher P Mason; Alexander W Tarr
Journal:  Molecules       Date:  2015-01-29       Impact factor: 4.411

5.  Correlation of Apolipoprotein B mRNA-editing Enzyme, Catalytic Polypeptide- like 3G Genetic Variant rs8177832 with HIV-1 Predisposition in Pakistani Population.

Authors:  Khurshid Iqbal; Muhammad Imran; Shafi Ullah; Muhsin Jamal; Yasir Waheed
Journal:  Curr HIV Res       Date:  2018       Impact factor: 1.581

6.  Prevalence of human leukocyte antigen HLA-B*57:01 in individuals with HIV in West and Central Africa.

Authors:  Didier K Ekouevi; Serge P Eholie; Malewe Kolou; Armel Poda; Zelica Diallo; Esther Konou; Tatiana Dokpomiwa; Jacques Zoungrana; Mounerou Salou; Lionèle Mba-Tchounga; André Bigot; Abdoul-Salam Ouedraogo; Marielle Bouyout-Akoutet
Journal:  BMC Immunol       Date:  2021-07-22       Impact factor: 3.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.